These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37620691)

  • 21. Recent advances in the treatment of Niemann pick disease type C: A mini-review.
    Matencio A; Navarro-Orcajada S; González-Ramón A; García-Carmona F; López-Nicolás JM
    Int J Pharm; 2020 Jun; 584():119440. PubMed ID: 32428546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of the Anionic Hydroxypropyl-β-cyclodextrin:Poly(decamethylenephosphate) Polyrotaxane and Evaluation of its Cholesterol Efflux Potential in Niemann-Pick C1 Cells.
    Egele K; Samaddar S; Schneider N; Thompson D; Wenz G
    J Mater Chem B; 2019 Jan; 7(4):528-537. PubMed ID: 31372225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoparticles containing β-cyclodextrin potentially useful for the treatment of Niemann-Pick C.
    Donida B; Raabe M; Tauffner B; de Farias MA; Machado AZ; Timm F; Kessler RG; Hammerschmidt TG; Reinhardt LS; Brito VB; Portugal RV; Bernardi A; Frozza R; Moura DJ; Giugliani R; Poletto F; Vargas CR
    J Inherit Metab Dis; 2020 May; 43(3):586-601. PubMed ID: 31943253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathecal 2-hydroxypropyl-beta-cyclodextrin in a single patient with Niemann-Pick C1.
    Maarup TJ; Chen AH; Porter FD; Farhat NY; Ory DS; Sidhu R; Jiang X; Dickson PI
    Mol Genet Metab; 2015; 116(1-2):75-9. PubMed ID: 26189084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Niemann-Pick Disease Type C: Induced Pluripotent Stem Cell-Derived Neuronal Cells for Modeling Neural Disease and Evaluating Drug Efficacy.
    Yu D; Swaroop M; Wang M; Baxa U; Yang R; Yan Y; Coksaygan T; DeTolla L; Marugan JJ; Austin CP; McKew JC; Gong DW; Zheng W
    J Biomol Screen; 2014 Sep; 19(8):1164-73. PubMed ID: 24907126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring the itinerary of lysosomal cholesterol in Niemann-Pick Type C1-deficient cells after cyclodextrin treatment.
    Feltes M; Gale SE; Moores S; Ory DS; Schaffer JE
    J Lipid Res; 2020 Mar; 61(3):403-412. PubMed ID: 31988149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normalization of cholesterol homeostasis by 2-hydroxypropyl-β-cyclodextrin in neurons and glia from Niemann-Pick C1 (NPC1)-deficient mice.
    Peake KB; Vance JE
    J Biol Chem; 2012 Mar; 287(12):9290-8. PubMed ID: 22277650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells.
    Rosenbaum AI; Zhang G; Warren JD; Maxfield FR
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5477-82. PubMed ID: 20212119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholesterol homeostatic responses provide biomarkers for monitoring treatment for the neurodegenerative disease Niemann-Pick C1 (NPC1).
    Tortelli B; Fujiwara H; Bagel JH; Zhang J; Sidhu R; Jiang X; Yanjanin NM; Shankar RK; Carillo-Carasco N; Heiss J; Ottinger E; Porter FD; Schaffer JE; Vite CH; Ory DS
    Hum Mol Genet; 2014 Nov; 23(22):6022-33. PubMed ID: 24964810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclodextrin triggers MCOLN1-dependent endo-lysosome secretion in Niemann-Pick type C cells.
    Vacca F; Vossio S; Mercier V; Moreau D; Johnson S; Scott CC; Montoya JP; Moniatte M; Gruenberg J
    J Lipid Res; 2019 Apr; 60(4):832-843. PubMed ID: 30709900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expanded access with intravenous hydroxypropyl-β-cyclodextrin to treat children and young adults with Niemann-Pick disease type C1: a case report analysis.
    Hastings C; Vieira C; Liu B; Bascon C; Gao C; Wang RY; Casey A; Hrynkow S
    Orphanet J Rare Dis; 2019 Oct; 14(1):228. PubMed ID: 31639011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential of histone deacetylase inhibitors in Niemann - Pick type C disease.
    Maceyka M; Milstien S; Spiegel S
    FEBS J; 2013 Dec; 280(24):6367-72. PubMed ID: 23992240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of 2-Hydroxypropyl-β-cyclodextrin in Niemann-Pick Disease Type C Model Mice and Its Pharmacokinetic Analysis in a Patient with the Disease.
    Tanaka Y; Yamada Y; Ishitsuka Y; Matsuo M; Shiraishi K; Wada K; Uchio Y; Kondo Y; Takeo T; Nakagata N; Higashi T; Motoyama K; Arima H; Mochinaga S; Higaki K; Ohno K; Irie T
    Biol Pharm Bull; 2015; 38(6):844-51. PubMed ID: 26027824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pluronic based β-cyclodextrin polyrotaxanes for treatment of Niemann-Pick Type C disease.
    Collins CJ; Loren BP; Alam MS; Mondjinou Y; Skulsky JL; Chaplain CR; Haldar K; Thompson DH
    Sci Rep; 2017 Apr; 7():46737. PubMed ID: 28452365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence of redox imbalance and mitochondrial dysfunction in Niemann-Pick type C 1 patients: the in vitro effect of combined therapy with antioxidants and β-cyclodextrin nanoparticles.
    Hammerschmidt TG; Donida B; Raabe M; Faverzani JL; de Fátima Lopes F; Machado AZ; Kessler RG; Reinhardt LS; Poletto F; Moura DJ; Vargas CR
    Metab Brain Dis; 2023 Feb; 38(2):507-518. PubMed ID: 36447062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lysosomal pH-inducible supramolecular dissociation of polyrotaxanes possessing acid-labile
    Tamura A; Nishida K; Yui N
    Sci Technol Adv Mater; 2016; 17(1):361-374. PubMed ID: 27877888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracerebroventricular Treatment with 2-Hydroxypropyl-β-Cyclodextrin Decreased Cerebellar and Hepatic Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Expression in Niemann-Pick Disease Type C Model Mice.
    Fukaura M; Ishitsuka Y; Shirakawa S; Ushihama N; Yamada Y; Kondo Y; Takeo T; Nakagata N; Motoyama K; Higashi T; Arima H; Kurauchi Y; Seki T; Katsuki H; Higaki K; Matsuo M; Irie T
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of multi-lactose-appended β-cyclodextrin and its cholesterol-lowering effects in Niemann-Pick type C disease-like HepG2 cells.
    Motoyama K; Nishiyama R; Maeda Y; Higashi T; Ishitsuka Y; Kondo Y; Irie T; Era T; Arima H
    Beilstein J Org Chem; 2017; 13():10-18. PubMed ID: 28179943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative comparison of the efficacy of various compounds in lowering intracellular cholesterol levels in Niemann-Pick type C fibroblasts.
    Wehrmann ZT; Hulett TW; Huegel KL; Vaughan KT; Wiest O; Helquist P; Goodson H
    PLoS One; 2012; 7(10):e48561. PubMed ID: 23144769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HPGCD outperforms HPBCD as a potential treatment for Niemann-Pick disease type C during disease modeling with iPS cells.
    Soga M; Ishitsuka Y; Hamasaki M; Yoneda K; Furuya H; Matsuo M; Ihn H; Fusaki N; Nakamura K; Nakagata N; Endo F; Irie T; Era T
    Stem Cells; 2015 Apr; 33(4):1075-88. PubMed ID: 25522247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.